Events & Webinars

Join us from 05–08 February 2026 in Antalya, Turkey, for the 2nd International Hereditary Cancers Congress.

As the conversation shifts from identifying genetic risk to active clinical application, Gene Solutions, in collaboration with ATC, invites you to an exclusive Satellite Symposium:​ “ctDNA across the Cancer Care Continuum – From Screening to Precision Care: Insights for High-Risk and Hereditary Populations”​

The 14th edition of the summit returns under the theme “Reaching New Heights in Breast Cancer Care” from 06–08 February 2026 in Penang, Malaysia, as we continue our mission to transform oncology through genomics.​

Join us at APBCS 2026 to exchange perspectives and see how we are elevating the standard of care together.​

Join us for a Satellite Symposium uniting leading experts to explore how AI-powered liquid biopsy and multi-omics are redefining the future of precision oncology

Powered by K-CONNECT APAC 2025, the Asia Pacific Precision Oncology Conference is set to mark a new chapter in the fight against cancer. Hosted in vibrant Hong Kong, this groundbreaking event unites the oncology community to explore the transformative role of AI and multi-omic technologies in cancer management

Singapore, September 2025 – Gene Solutions will host an exclusive symposium titled “Advancing Precision Oncology: MRD and Multi-Omics in Solid Tumors” during the 10th Annual Scientific Meeting of the Singapore

We are excited to announce that Gene Solutions will be actively participating in ESMO Asia 2024. Our presence at the event underscores our commitment to enhancing cancer care through next-generation technologies and collaborative research.

Gene Solutions is proud to participate in the Thai Society of Clinical Oncology (TSCO) 2024 Annual Conference, where we will be held a symposium titled “The Application of ctDNA in Monitoring the Minimal Residual Disease in Precision Oncology.” 

We are pleased to announce our participation in the 35th Annual Scientific Congress of the Malaysian Oncological Society (ASCOMOS), taking place from 11th to 13th October at the Setia Spice Convention Centre in Penang.

We are proud to announce that Dr. Tang Hung Sang, Medical Director of Gene Solutions, along with our brilliant medical team, will present the Latest Cases Series With De Novo

Gene Solutions is excited to announce our participation in the 2024 ASCO Breakthrough Meeting. On July 12, 2024, we are honored to receive the Conquer Cancer® Merit Award for our “K-DETEK” study of the SPOT-MAS assay. This award recognizes our dedication to advancing cell-free DNA-based multi-cancer detection.

Gene Solutions is proud to participate in the Biomarkers and Precision Oncology Forum (BPOF) and APGCS 2024 in Singapore. Our involvement highlights our dedication to advancing precision oncology. We will present our latest research and engage with global and regional experts to drive innovation in cancer care.